Investors
EPOK Therapeutics successfully closed its seed round of financing from international angel investors
Partners
Antibody engineering and characterization
In vivo characterization of candidates
Investors
EPOK Therapeutics successfully closed its seed round of financing from international angel investors
Partners
Antibody engineering and characterization
In vivo characterization of candidates